Publicly available resource monitors the development of therapies to treat and prevent disease
WASHINGTON, March 18, 2020 — The Milken Institute is launching a resource to help the public and policymakers track progress in the development of treatments and vaccines for COVID-19.
The tracker is available online at https://milkeninstitute.org/covid-19-tracker. It is developed and maintained by FasterCures, a center of the Milken Institute, with an Advisory Council comprised of a Nobel Laureate researcher, former FDA chiefs, and industry leaders.
“We seek to accelerate efforts to find new treatments or vaccines, amplify what’s working, hold the system and its players accountable, and expand the global discussion about how to create durable, long term solutions,” says Esther Krofah, executive director of FasterCures. “COVID-19 is putting that approach to the test. We hope to be a resource promoting effective approaches and strategies."
The Milken Institute COVID-19 vaccine development and treatment tracker is compiled from publicly available sources and will be updated regularly. It will grow to include FDA-approved indications where applicable, as well as basic information about the focus of each clinical trial.
The Milken Institute welcomes input on new treatments and vaccines in development. Please email [email protected] with tips.
Related Content
-
Citi's Christopher Hite Joins FasterCures Advisory Board
Hite’s decades of healthcare finance experience will enhance center’s approach to biomedical innovation WASHINGTON, August 13, 2019 – FasterCures, a center of the Milken Institute, today announced the appointment of Christopher Hite, Vice...Read Article -
CoRE-Milken Institute Regional Multi-Stakeholder Patient Engagement Roundtable Report
Accelerating Patient Engagement for More Resilient Health Systems The Milken Institute, Centre of Regulatory Excellence (CoRE), SingHealth Duke-NUS Global Health Institute, Rainbow Across Borders, and Patient Focused Medicines Development...Read ArticleImageYeen Chong
Associate Director, Milken Institute InternationalYeen Chee Chong is an associate director for Milken Institute International. Based in Singapore, he oversees and manages strategic communications with a wide range of global and regional media publications and partners. Chong works closely with colleagues in both Asia and the United States on planning and implementing global public relations and social media campaigns. -
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization – US House Energy & Commerce Committee
Submitted electronically The Honorable Anna Eshoo Committee on Energy and Commerce US House of Representatives Washington, DC 20515 The Honorable Richard Hudson Committee on Energy and Commerce US House of Representatives Washington, DC...Read LetterImageEsther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives. -
Patient-Focused Drug Development Meetings: Smart Practices from Community Leaders
FasterCures, a center of the Milken Institute, designed this guide for patient advocacy organizations that are interested in hosting, or are currently planning, an externally led patient-focused drug development (PFDD) meeting. We have...Read Report -
Misophonia - A Giving Smarter Guide
While some sounds can be annoying for most people, for a few, certain sounds like chewing, sniffling, or pen clicking can trigger an intense physical and emotional response. Those with this condition can experience increased heart rate...Read Report11James A. Randall and Cara Altimus, PhD -
Weighing Down America: 2020 Update
The economic and social cost of obesity in America is at an all-time high and continues to rise. We estimate its cost to be roughly 6.76 percent of gross domestic product (GDP) in 2018 compared to 5.57 percent in 2014. The latest statistics...Read Report11 11
Joseph Bendix, Claude Lopez, and Ken Sagynbekov -
Framing the Issues: Digital Mental Health in Asia
More than a decade since the World Health Organization declared “no health without mental health,” its message bears heeding more than ever. Many countries have suppressed certain infectious diseases and chronic physical illnesses, but...Read ReportImageQuintus Lim
Associate Director, Asia, Milken Institute InternationalQuintus Lim is an associate director of policy and programs for the International pillar at the Milken Institute. He focuses on policy areas such as R&D financing, technological adoption across domains such as health, food, agriculture, finance, and the broader economy, and issues of ecosystem building. -
Food and Agriculture in Asia: Investing in Resilience, Health, and Sustainability
As the world reels from multiple crises in rapid succession, the opportunities to set food systems on a more sustainable and equitable path have never been more favorable, and in turn, the importance of multi-stakeholder convenings cannot...Read Report -
Clinical Developments in Follicular Lymphoma
Follicular lymphoma (FL) is a rare, slow-growing cancer that affects certain blood cells. People experiencing this form of non-Hodgkin lymphoma face multiple relapses over the course of their disease, which can run for years and sometimes...Read ReportImageCaitlyn Barrett, PhD
Director, Science Philanthropy Accelerator for Research and Collaboration (SPARC) team, Milken Institute Strategic PhilanthropyCaitlyn Barrett, PhD, is a director on the Science Philanthropy Accelerator for Research and Collaboration (SPARC) team at Milken Institute Strategic Philanthropy. Her scientific expertise in cancer biology and neurodegeneration in addition to her experience in grant and program management, stakeholder engagement, and program analysis are brought to bear as she partners with philanthropists to maximize their impact on the biomedical ecosystem. -
Coalition-Building Between the US and China on Women’s Cancer Detection, Treatment, and Care
Cancer is one of the leading causes of death in the US and China. Of the top 10 (by incidence) cancers in China, four are women’s cancers, including breast and cervical cancers. Despite successes in cancer control and prevention in both...Read Report -
What Kills Americans: Growth of Metabolic Contributors
The most common way to understand the impact of a disease is to track its rates of prevalence and mortality because these metrics are derived from easily collected data. However, prevalence and mortality rates fail to capture whether a...View Research -
The Reinvention of Prevention: How to Fund and Finance a Pivot to a Prevention-First Healthcare System
As part of the debut of the Milken Institute’s Project Prevent initiative in 2024, the Institute conducted a series of interviews with 35 key stakeholders and experts in health, finance, philanthropy, pensions, and public policy to explore...Read Report